KR20110041670A - 대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지 - Google Patents
대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지 Download PDFInfo
- Publication number
- KR20110041670A KR20110041670A KR1020090098609A KR20090098609A KR20110041670A KR 20110041670 A KR20110041670 A KR 20110041670A KR 1020090098609 A KR1020090098609 A KR 1020090098609A KR 20090098609 A KR20090098609 A KR 20090098609A KR 20110041670 A KR20110041670 A KR 20110041670A
- Authority
- KR
- South Korea
- Prior art keywords
- bacteriophage
- shigella
- coli
- present
- culture
- Prior art date
Links
- 241001515965 unidentified phage Species 0.000 title claims abstract description 104
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 71
- 241000607768 Shigella Species 0.000 title claims abstract description 67
- 230000002147 killing effect Effects 0.000 title abstract description 21
- 201000010099 disease Diseases 0.000 claims abstract description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 17
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 16
- 239000004599 antimicrobial Substances 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 235000013373 food additive Nutrition 0.000 claims abstract description 12
- 239000002778 food additive Substances 0.000 claims abstract description 12
- 239000003674 animal food additive Substances 0.000 claims abstract description 11
- 241000894006 Bacteria Species 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- 208000015181 infectious disease Diseases 0.000 claims description 11
- 239000003242 anti bacterial agent Substances 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims 2
- 239000003139 biocide Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 abstract description 8
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 244000005700 microbiome Species 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 241001138501 Salmonella enterica Species 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 239000006150 trypticase soy agar Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 241000237858 Gastropoda Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000607760 Shigella sonnei Species 0.000 description 3
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 241000702202 Siphoviridae Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000003275 alpha amino acid group Chemical group 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000001066 phage therapy Methods 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229940115939 shigella sonnei Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000220479 Acacia Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000588732 Atlantibacter hermannii Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101710112752 Cytotoxin Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000588720 Escherichia fergusonii Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 206010065764 Mucosal infection Diseases 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000004353 Polyethylene glycol 8000 Substances 0.000 description 1
- 241000588733 Pseudescherichia vulneris Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000533331 Salmonella bongori Species 0.000 description 1
- 241000266403 Salmonella enterica subsp. enterica serovar Choleraesuis Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108010079723 Shiga Toxin Proteins 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040550 Shigella infections Diseases 0.000 description 1
- 241000588717 Shimwellia blattae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229940037395 electrolytes Drugs 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000000369 enteropathogenic effect Effects 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940085678 polyethylene glycol 8000 Drugs 0.000 description 1
- 235000019446 polyethylene glycol 8000 Nutrition 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00031—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
Abstract
Description
번호 | 기탁번호 | 균주의 종류 | 사멸여부 |
1 | KCTC2223 | Escherichia coli | + |
2 | KCTC2293 | Escherichia coli | + |
3 | ATCC21278 | Escherichia coli | + |
4 | DSM4481 | Escherichia blattae | - |
5 | DSM4560 | Escherichia hermannii | - |
6 | DSM4564 | Escherichia vulneris | - |
7 | DSM13698 | Escherichia fergusonii | - |
8 | KCTC2518 | Shigella sonnei | + |
9 | DSM5570 | Shigella sonnei | + |
10 | DSM 14848 | Salmonella choleraesuis indica | - |
11 | DSM 14846 | Salmonella choleraesuis choleraesuis | - |
12 | DSM 13772 | Salmonella bongori | - |
13 | DSM 9386 | Salmonella choleraesuis arizonae | - |
14 | DSM 9221 | Salmonella choleraesuis hountenae | - |
15 | DSM 9220 | Salmonella choleraesuis salamae | - |
16 | ATCC 13311 | Salmonella typhimurium | - |
17 | ATCC 13076 | Salmonella enteritidis | - |
18 | DSM 14847 | Salmonella choleraesuis diarizonae | - |
Claims (11)
- 대장균 또는 시겔라속(Shigella) 균에 특이적 사멸능을 갖는 박테리오파지 (기탁번호 KCTC 11428BP).
- 제1항에 있어서, 상기 박테리오파지는 서열번호 1의 염기서열로 표시되는 유전체를 갖는 박테리오 파지.
- 제1항에 있어서, 상기 시겔라속 균은 시겔라소네이(Shigella sonnei ) 균인 박테리오 파지.
- 제1항의 박테리오파지 또는 이의 배양물을 유효성분으로 함유하는 항균제.
- 제4항에 있어서, 상기 항균제는 대장균 또는 시겔라속(Shigella) 균을 사멸시키는 것인 항균제.
- 제5항에 있어서, 상기 시겔라속 균은 시겔라소네이(Shigella sonnei ) 균인 항균제.
- 제1항의 박테리오파지 또는 이의 배양물을 유효성분으로 함유하는 대장균 또 는 시겔라속 균에 의해 유발되는 질환의 예방 또는 치료용 약학적 조성물.
- 제7항에 있어서, 상기 대장균에 의해 유발되는 질환은 대장균 감염증인 약학적 조성물.
- 제7항에 있어서, 상기 시겔라속 균에 의해 유발되는 질환은 세균성 이질인 약학적 조성물.
- 제1항의 박테리오파지 또는 이의 배양물을 포함하는 사료첨가제.
- 제1항의 박테리오파지 또는 이의 배양물을 포함하는 식품첨가제.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090098609A KR101101376B1 (ko) | 2009-10-16 | 2009-10-16 | 대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090098609A KR101101376B1 (ko) | 2009-10-16 | 2009-10-16 | 대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110041670A true KR20110041670A (ko) | 2011-04-22 |
KR101101376B1 KR101101376B1 (ko) | 2012-01-02 |
Family
ID=44047484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090098609A KR101101376B1 (ko) | 2009-10-16 | 2009-10-16 | 대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101101376B1 (ko) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101299179B1 (ko) * | 2012-04-18 | 2013-08-22 | 씨제이제일제당 (주) | 신규 박테리오파지 및 이를 포함하는 항균 조성물 |
WO2014133290A1 (en) * | 2013-02-27 | 2014-09-04 | Cj Cheiljedang Corporation | Novel bacteriophage and antibacterial composition comprising the same |
WO2014133289A1 (en) * | 2013-02-27 | 2014-09-04 | Cj Cheiljedang Corporation | Novel bacteriophage and antibacterial composition comprising the same |
KR20150117445A (ko) * | 2014-04-10 | 2015-10-20 | 씨제이제일제당 (주) | 신규 박테리오파지 및 이를 포함하는 조성물 |
WO2016108538A1 (ko) * | 2014-12-29 | 2016-07-07 | 주식회사 인트론바이오테크놀로지 | 신규한 장출혈성 대장균 박테리오파지 Esc-CHP-1 및 이의 장출혈성 대장균 증식 억제 용도 |
WO2016108542A1 (ko) * | 2014-12-30 | 2016-07-07 | 주식회사 인트론바이오테크놀로지 | 신규한 장침입성 대장균 박테리오파지 Esc-COP-4 및 이의 장침입성 대장균 증식 억제 용도 |
WO2016108540A1 (ko) * | 2014-12-30 | 2016-07-07 | 주식회사 인트론바이오테크놀로지 | 신규한 장병원성 대장균 박테리오파지 Esc-CHP-2 및 이의 장병원성 대장균 증식 억제 용도 |
US9950018B2 (en) | 2014-04-15 | 2018-04-24 | Cj Cheiljedang Corporation | Bacteriophage and composition comprising same |
EP3253215A4 (en) * | 2015-01-23 | 2018-07-18 | Intralytix, Inc. | Novel shigella bacteriophages and uses thereof |
WO2018101595A3 (ko) * | 2016-11-30 | 2018-08-09 | 주식회사 인트론바이오테크놀로지 | 대장균 박테리오파지 Esc-COP-9 및 이의 병원성 대장균 증식 억제 용도 |
KR20190018968A (ko) * | 2017-08-16 | 2019-02-26 | 경북대학교 산학협력단 | 병원성 장내세균에 대해 사멸능을 갖는 신규 박테리오파지 및 이의 용도 |
US10265355B2 (en) | 2014-12-30 | 2019-04-23 | Intron Biotechnology, Inc. | Shigatoxin-producing F18 type E. coli bacteriophage esc-COP-1 and use thereof for inhibiting proliferation of shigatoxin-producing F18 type E. coli |
US10286020B2 (en) | 2014-04-15 | 2019-05-14 | Cj Cheiljedang Corporation | Bacteriophage and composition comprising same |
CN115141811A (zh) * | 2021-09-27 | 2022-10-04 | 江苏省农业科学院 | 一种宽裂解谱肠出血性大肠杆菌噬菌体、包括噬菌体的抑菌剂及制备方法和应用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016003307A1 (en) | 2014-07-02 | 2016-01-07 | Limited Liability Company "Bphage" | Bacteriophage strains, compositions and related methods |
WO2016168560A1 (en) | 2015-04-16 | 2016-10-20 | Kennesaw State University Research And Service Foundation, Inc. | Escherichia coli o157:h7 bacteriophage φ241 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1458856T3 (da) | 2001-12-13 | 2012-07-09 | Nestle Sa | Isolerede fager og deres anvendelse i fødevare- eller kæledyrsfoderprodukter |
KR100943041B1 (ko) * | 2007-09-20 | 2010-02-19 | 재단법인서울대학교산학협력재단 | 시포비리대에 속하는 박테리오파지 및 이를 포함하는 세균사멸용 조성물 |
KR100949389B1 (ko) * | 2007-10-08 | 2010-03-25 | 재단법인서울대학교산학협력재단 | 박테리오파지 kctc11120bp를 함유하는 세균증식 억제 또는 사멸용 제제 |
KR101101604B1 (ko) * | 2009-04-22 | 2012-01-02 | 경북대학교 산학협력단 | 병원성 장내세균을 사멸시키는 박테리오파지 |
-
2009
- 2009-10-16 KR KR1020090098609A patent/KR101101376B1/ko not_active IP Right Cessation
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101299179B1 (ko) * | 2012-04-18 | 2013-08-22 | 씨제이제일제당 (주) | 신규 박테리오파지 및 이를 포함하는 항균 조성물 |
WO2014133290A1 (en) * | 2013-02-27 | 2014-09-04 | Cj Cheiljedang Corporation | Novel bacteriophage and antibacterial composition comprising the same |
WO2014133289A1 (en) * | 2013-02-27 | 2014-09-04 | Cj Cheiljedang Corporation | Novel bacteriophage and antibacterial composition comprising the same |
US9862935B2 (en) | 2013-02-27 | 2018-01-09 | Cj Cheiljedang Corporation | Bacteriophage and antibacterial composition comprising the same |
CN105324481A (zh) * | 2013-02-27 | 2016-02-10 | Cj第一制糖株式会社 | 新颖噬菌体和包括所述新颖噬菌体的抗细菌组成物 |
US9657277B2 (en) | 2013-02-27 | 2017-05-23 | Cj Cheiljedang Corporation | Bacteriophage and antibacterial composition comprising the same |
US11785948B2 (en) | 2014-04-10 | 2023-10-17 | Cj Cheiljedang Corporation | Bacteriophage and composition comprising same |
KR20150117445A (ko) * | 2014-04-10 | 2015-10-20 | 씨제이제일제당 (주) | 신규 박테리오파지 및 이를 포함하는 조성물 |
US10577590B2 (en) | 2014-04-10 | 2020-03-03 | Cj Cheiljedang Corporation | Bacteriophage and composition comprising same |
US10925909B2 (en) | 2014-04-15 | 2021-02-23 | Cj Cheiljedang Corporation | Bacteriophage and composition comprising same |
US9950018B2 (en) | 2014-04-15 | 2018-04-24 | Cj Cheiljedang Corporation | Bacteriophage and composition comprising same |
US10286020B2 (en) | 2014-04-15 | 2019-05-14 | Cj Cheiljedang Corporation | Bacteriophage and composition comprising same |
US10265353B2 (en) | 2014-12-29 | 2019-04-23 | Intron Biotechnology, Inc. | Enterohemorrhagic E. coli bacteriophage Esc-CHP-1 and use thereof for inhibiting proliferation of enterohemorrhagic E. coli |
WO2016108538A1 (ko) * | 2014-12-29 | 2016-07-07 | 주식회사 인트론바이오테크놀로지 | 신규한 장출혈성 대장균 박테리오파지 Esc-CHP-1 및 이의 장출혈성 대장균 증식 억제 용도 |
WO2016108540A1 (ko) * | 2014-12-30 | 2016-07-07 | 주식회사 인트론바이오테크놀로지 | 신규한 장병원성 대장균 박테리오파지 Esc-CHP-2 및 이의 장병원성 대장균 증식 억제 용도 |
CN107208067A (zh) * | 2014-12-30 | 2017-09-26 | 尹特荣生物科技株式会社 | 新型肠侵袭性大肠杆菌噬菌体Esc‑COP‑4及其用于抑制肠侵袭性大肠杆菌增殖的用途 |
WO2016108542A1 (ko) * | 2014-12-30 | 2016-07-07 | 주식회사 인트론바이오테크놀로지 | 신규한 장침입성 대장균 박테리오파지 Esc-COP-4 및 이의 장침입성 대장균 증식 억제 용도 |
US10265356B2 (en) | 2014-12-30 | 2019-04-23 | Intron Biotechnology, Inc. | Enteroinvasive E. coli bacteriophage Esc-COP-4 and use thereof for inhibiting proliferation of enteroinvasive E. coli |
US10265354B2 (en) | 2014-12-30 | 2019-04-23 | Intron Biotechnology, Inc. | Enteropathogenic E. coli bacteriophage Esc-CHP-2 and use thereof for inhibiting proliferation of enteropathogenic E. coli |
US10265355B2 (en) | 2014-12-30 | 2019-04-23 | Intron Biotechnology, Inc. | Shigatoxin-producing F18 type E. coli bacteriophage esc-COP-1 and use thereof for inhibiting proliferation of shigatoxin-producing F18 type E. coli |
EP3253215A4 (en) * | 2015-01-23 | 2018-07-18 | Intralytix, Inc. | Novel shigella bacteriophages and uses thereof |
US10711252B2 (en) | 2015-01-23 | 2020-07-14 | Intralytix, Inc. | Shigella bacteriophages and uses thereof |
AU2016209252B2 (en) * | 2015-01-23 | 2020-07-16 | Intralytix, Inc. | Novel Shigella bacteriophages and uses thereof |
CN108471756A (zh) * | 2015-01-23 | 2018-08-31 | 因特拉蒂克斯有限公司 | 新型志贺菌噬菌体及其用途 |
WO2018101595A3 (ko) * | 2016-11-30 | 2018-08-09 | 주식회사 인트론바이오테크놀로지 | 대장균 박테리오파지 Esc-COP-9 및 이의 병원성 대장균 증식 억제 용도 |
US11213050B2 (en) | 2016-11-30 | 2022-01-04 | Intron Biotechnology, Inc. | Escherichia coli bacteriophage Esc-COP-9 and use for inhibiting proliferation of pathogenic Escherichia coli thereof |
KR20190018968A (ko) * | 2017-08-16 | 2019-02-26 | 경북대학교 산학협력단 | 병원성 장내세균에 대해 사멸능을 갖는 신규 박테리오파지 및 이의 용도 |
CN115141811A (zh) * | 2021-09-27 | 2022-10-04 | 江苏省农业科学院 | 一种宽裂解谱肠出血性大肠杆菌噬菌体、包括噬菌体的抑菌剂及制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
KR101101376B1 (ko) | 2012-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101101376B1 (ko) | 대장균 또는 시겔라속 균에 특이적 사멸능을 갖는 박테리오파지 | |
KR101070938B1 (ko) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 | |
KR101151516B1 (ko) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 | |
CN107250352B (zh) | 新型肠致病性大肠杆菌噬菌体Esc-CHP-2及其用于抑制肠致病性大肠杆菌增殖的用途 | |
KR101151532B1 (ko) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 | |
KR101261873B1 (ko) | 식중독을 유발하는 살모넬라에 특이적 사멸능을 갖는 박테리오파지 | |
Ghasemi et al. | Preliminary characterization of Lactococcus garvieae bacteriophage isolated from wastewater as a potential agent for biological control of lactococcosis in aquaculture | |
KR101591795B1 (ko) | 신규 박테리오파지 및 이를 포함하는 조성물 | |
US10898531B2 (en) | Vibrio parahaemolyticus bacteriophage Vib-PAP-5 and use thereof for suppressing proliferation of Vibrio parahaemolyticus bacteria | |
US11679138B2 (en) | Vibrio parahaemolyticus bacteriophage Vib-PAP-7 and use of same for inhibiting vibrio parahaemolyticus bacteria proliferation | |
CN110621775B (zh) | 新型铜绿假单胞菌噬菌体Pse-AEP-4及其用于抑制铜绿假单胞菌的增殖的用途 | |
CN108179136B (zh) | 大肠杆菌噬菌体Esc-COP-9及其致病性大肠杆菌增殖抑制用途 | |
KR102396828B1 (ko) | 내열성 박테리오파지 ts3, ts6, ts13 및 이를 포함하는 살모넬라 억제용 조성물 | |
CN113166730A (zh) | 新型猪链球菌噬菌体str-sup-1及其在抑制猪链球菌细菌增殖方面的用途 | |
KR101859973B1 (ko) | 신규한 에로모나스 하이드로필라 박테리오파지 Aer-HYP-1 및 이의 에로모나스 하이드로필라 균 증식 억제 용도 | |
CN104059869B (zh) | 一株海洋解淀粉芽孢杆菌及其培养方法和应用 | |
US11213050B2 (en) | Escherichia coli bacteriophage Esc-COP-9 and use for inhibiting proliferation of pathogenic Escherichia coli thereof | |
US11679137B2 (en) | Vibrio parahaemolyticus bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation of Vibrio parahaemoliticus bacteria | |
CN111742046A (zh) | 新型嗜水气单胞菌噬菌体Aer-HYP-3及其在抑制嗜水气单胞菌细菌生长方面的用途 | |
TWI846157B (zh) | 一種沙福芽孢桿菌(Bacillus safensis)及其用途 | |
KR102423986B1 (ko) | 액티노바실러스 플루로뉴모니애 균에 대하여 용균활성을 갖는 항균물질 및 이의 제조방법 | |
CN112646785B (zh) | 一株耐高温烈性变形杆菌噬菌体rdp-sa-20018及其应用 | |
CN110023492B (zh) | 新型格氏乳球菌噬菌体lac-gap-3及其用于抑制格氏乳球菌细菌增殖的用途 | |
CN109477075B (zh) | 新型支气管败血鲍特菌噬菌体Bor-BRP-1及其抑制支气管败血鲍特菌增殖的用途 | |
KR20230010741A (ko) | 병원성 대장균의 증식을 억제하기 위한 조성물 및 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20091016 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110426 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20111219 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20111226 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20111226 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20150807 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20150807 Start annual number: 5 End annual number: 5 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20171006 |